IMMUNOGEN INC Uncategorized Contracts & Agreements

31 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter dated as of September 18, 2023 between the Registrant and Lauren White
IMMUNOGEN INC
Biotechnology
2023
First Amendment to Offer Letter dated as of December 29, 2022 between the Registrant and Michael J. Vasconcelles
IMMUNOGEN INC
Biotechnology
2023
Offer Letter dated as of December 29, 2022 between the Registrant and Michael J. Vasconcelles
IMMUNOGEN INC
Biotechnology
2023
Description of Securities
IMMUNOGEN INC
Biotechnology
MA
2023
First Amendment to Agreements dated as of December 9, 2013 by and between the Registrant and Eli Lilly and Company
IMMUNOGEN INC
Biotechnology
2022
Description of Securities
IMMUNOGEN INC
Biotechnology
MA
2021
Open Market Sale AgreementSM, dated December 18, 2020, by and between ImmunoGen, Inc. and Jefferies LLC
IMMUNOGEN INC
Biotechnology
NY
2020
Open Market Sale AgreementSM, dated September 25, 2020, by and between ImmunoGen, Inc. and Jefferies LLC
IMMUNOGEN INC
Biotechnology
NY
2020
Description of Securities
IMMUNOGEN INC
Biotechnology
2020
Multi-Target Agreement, dated as of December 19, 2011, by and between the Company and Eli Lilly
IMMUNOGEN INC
Biotechnology
IN
2018
Options Granted
IMMUNOGEN INC
Biotechnology
MA
2016
Options Granted
IMMUNOGEN INC
Biotechnology
MA
2016
Options Granted
IMMUNOGEN INC
Biotechnology
MA
2016
Options Exercised
IMMUNOGEN INC
Biotechnology
MA
2016
Options Exercised
IMMUNOGEN INC
Biotechnology
MA
2016
830 Winter Street Waltham, Massachusetts 02451 (the Building) THIRD AMENDMENT
IMMUNOGEN INC
Biotechnology
2016
CONFIDENTIAL TREATMENT REQUESTED
IMMUNOGEN INC
Biotechnology
2015
[ImmunoGen Letterhead]
IMMUNOGEN INC
Biotechnology
2014
CONFIDENTIAL TREATMENT REQUESTED FIRST AMENDMENT TO AGREEMENTS
IMMUNOGEN INC
Biotechnology
2014
FIRST AMENDMENT TO MULTI-TARGET AGREEMENT
IMMUNOGEN INC
Biotechnology
MA
2013
Options Exercised
IMMUNOGEN INC
Biotechnology
MA
2012
Options Exercised
IMMUNOGEN INC
Biotechnology
MA
2012
Options Exercised
IMMUNOGEN INC
Biotechnology
MA
2012
MULTI-TARGET AGREEMENT
IMMUNOGEN INC
Biotechnology
IN
2012
MULTI-TARGET AGREEMENT
IMMUNOGEN INC
Biotechnology
MA
2012
IMMUNOGEN, INC. 2006 EMPLOYEE, DIRECTOR AND CONSULTANT EQUITYINCENTIVE PLAN (as amended and restated through November 12, 2008)
IMMUNOGEN INC
Biotechnology
MA
2008
SECURITIESPURCHASE AGREEMENT
IMMUNOGEN INC
Biotechnology
NY
2008
PROPRIETARYINFORMATION, INVENTIONS, AND COMPETITION AGREEMENT
IMMUNOGEN INC
Biotechnology
MA
2008
SEVERANCEAGREEMENT
IMMUNOGEN INC
Biotechnology
MA
2008
SCALE UP AGREEMENT
IMMUNOGEN INC
Biotechnology
2007
ImmunoGen, Inc.
IMMUNOGEN INC
Biotechnology
2005